All Stories

  1. Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma

    Article • Cancer Management and Research, May 2019, Dove Medical Press

    Dr Masatoshi Eto, Junichi Inokuchi

  2. Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan

    Article • International Journal of Urology, October 2018, Wiley

    Dr Masatoshi Eto, Dr Go GK Kimura

  3. Collateral resistance to taxanes in enzalutamide-resistant prostate cancer through aberrant androgen receptor and its variants

    Article • Cancer Science, August 2018, Wiley

    Dr Masatoshi Eto

  4. Serum testosterone before and during androgen-deprivation therapy, and prognosis between cigarette smokers and nonsmokers with metastatic prostate cancer

    Article • Andrologia, August 2018, Wiley

    Dr Masatoshi Eto

  5. Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide

    Article • The Prostate, May 2018, Wiley

    Dr Masatoshi Eto

  6. IJU this issue

    Article • International Journal of Urology, December 2017, Wiley

    Dr Masatoshi Eto

  7. Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy

    Article • International Journal of Urology, November 2017, Wiley

    Dr Masatoshi Eto

  8. Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study

    Article • International Journal of Cancer, September 2017, Wiley

    Dr Masatoshi Eto, Keitaro Matsuo

  9. Contrasting effects of cyclophosphamide on anti-CTL-associated protein 4 blockade therapy in two mouse tumor models

    Article • Cancer Science, August 2017, Wiley

    Dr Masatoshi Eto

  10. Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan

    Article • Cancer Science, July 2017, Wiley

    Dr Masatoshi Eto, Keitaro Matsuo

  11. Reality of nerve sparing and surgical margins in surgeons’ early experience with robot-assisted radical prostatectomy in Japan

    Article • International Journal of Urology, January 2017, Wiley

    Dr Masatoshi Eto

  12. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study)

    Article • LUTS Lower Urinary Tract Symptoms, November 2016, Wiley

    Dr Masatoshi Eto

  13. Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy

    Article • Cancer Science, June 2016, Wiley

    Dr Masatoshi Eto

  14. Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer

    Article • International Journal of Urology, April 2016, Wiley

    Dr Masatoshi Eto